Last reviewed · How we verify
Difluprednate Ophthalmic Emulsion — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Difluprednate Ophthalmic Emulsion (Difluprednate Ophthalmic Emulsion) — Sirion Therapeutics, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Difluprednate Ophthalmic Emulsion TARGET | Difluprednate Ophthalmic Emulsion | Sirion Therapeutics, Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Difluprednate Ophthalmic Emulsion CI watch — RSS
- Difluprednate Ophthalmic Emulsion CI watch — Atom
- Difluprednate Ophthalmic Emulsion CI watch — JSON
- Difluprednate Ophthalmic Emulsion alone — RSS
Cite this brief
Drug Landscape (2026). Difluprednate Ophthalmic Emulsion — Competitive Intelligence Brief. https://druglandscape.com/ci/difluprednate-ophthalmic-emulsion. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab